FOLLICULAR LYMPHOMA (FL)
Clinical trials for FOLLICULAR LYMPHOMA (FL) explained in plain language.
Never miss a new study
Get alerted when new FOLLICULAR LYMPHOMA (FL) trials appear
Sign up with your email to follow new studies for FOLLICULAR LYMPHOMA (FL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a Three-Drug cocktail replace chemo for follicular lymphoma?
Disease control Not yet recruitingThis phase 3 trial is testing whether a combination of three targeted drugs—orelabrutinib, obinutuzumab, and lenalidomide—can work as well as or better than standard chemotherapy for people with previously untreated follicular lymphoma. The goal is to see if this chemo-free appro…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE3 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Smart blood pressure cuffs could protect cancer patients from heart risks
Disease control Not yet recruitingThis pilot study tests whether a connected blood pressure monitor, supervised daily by a healthcare assistant, helps patients with blood cancers like CLL or lymphoma stick to home monitoring. The goal is to catch and manage high blood pressure early, a common side effect of BTK i…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: NA • Sponsor: Centre Hospitalier de la côte Basque • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Chemo-free triplet aims to outsmart incurable lymphoma
Disease control Not yet recruitingThis study tests a chemotherapy-free combination of three drugs (sonrotoclax, zanubrutinib, and rituximab) in 52 adults with previously untreated follicular lymphoma. The goal is to see if this approach can produce deeper and longer-lasting remissions while being easier to tolera…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Colombia launches first CAR-T trial for Hard-to-Treat blood cancers
Disease control Not yet recruitingThis study aims to bring CAR-T cell therapy to Colombia for people with certain blood cancers that have come back or not responded to treatment. It has two parts: first, setting up the necessary partnerships and facilities to produce the therapy locally, and second, testing the s…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: NA • Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New CAR-T therapy aims to control Hard-to-Treat lymphoma
Disease control Not yet recruitingThis study tests a new treatment called TC011 for adults with follicular lymphoma that has come back or not responded to at least two prior therapies. TC011 is a type of CAR-T cell therapy that targets cancer cells. The main goal is to see how many patients' tumors shrink or disa…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental Dual-Targeting T-Cell therapy takes on tough lymphomas
Disease control Not yet recruitingThis early-phase trial will test a new type of immune cell therapy called bispecific AbTCR T-cells in 3 adults with relapsed or refractory B-cell lymphoma (including diffuse large B-cell, follicular, and Burkitt lymphoma). The cells are designed to target two proteins (CD19 and C…
Matched conditions: FOLLICULAR LYMPHOMA (FL)
Phase: EARLY_PHASE1 • Sponsor: First Affiliated Hospital Xi'an Jiaotong University • Aim: Disease control
Last updated Jun 26, 2026 17:44 UTC